[1] Shen N, Mo L Q, Hu F, et al. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats[J].CNS Neurosci Ther, 2014, 20(8): 728-736.
[2] Marcus D J, Zee M, Hughes A, et al. Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase[J].Mol Pain, 2015, 11(1): 34.
[3] Robinson C R, Dougherty P M. Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy[J]. Neuroscience, 2015, 285: 1-10.
[4] Freitas-Andrade M, Wang N, Bechberger J F, et al. Targeting MAPK phosphorylation of Connexin43 provides neuroprotection in stroke[J].J Exp Med, 2019, 216(4): 916-935.
[5] Tonkin R S, Mao Y, O’Carroll S J, et al. Gap junction proteins and their role in spinal cord injury[J].Front Molec Neurosci, 2015, 7: 102.
[6] Wang A, Xu C. The role of connexin43 in neuropathic pain induced by spinal cord injury[J]. Acta Biochim Biophy Sin, 2019, 51(6): 555-561.
[7] Epifantseva I, Shaw R M. Intracellular trafficking pathways of Cx43 gap junction channels[J]. Biochim Biophys Act, 2018, 1860(1): 40-47.
[8] Hang L H, Li S N, Luo H, et al. Connexin 43 mediates CXCL12 production from spinal dorsal horn to maintain bone cancer pain in rats[J].Neurochem Res, 2016, 41(5): 1200-1208.
[9] Chen M J, Kress B, Han X, et al. Astrocytic Cx43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury[J]. Glia, 2012, 60(11): 1660-1670.
[10] Spray D C, Hanani M. Gap junctions, pannexins and pain[J].Neurosci.Lett, 2017.
[11] Yang H, Yan H, Li X, et al. Inhibition of connexin 43 and phosphorylated NR2B in spinal astrocytes attenuates bone cancer pain in mice[J].Front Cell Neurosci, 2018, 12: 129.
[12] Morioka N, Miyauchi K, Miyashita K, et al. Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes[J].J Neurorochem, 2019.
[13] Choi S R, Roh D H, Yoon S Y, et al. Astrocyte sigma-1 receptors modulate connexin 43 expression leading to the induction of below-level mechanical allodynia in spinal cord injured mice[J]. Neuropharmacology, 2016, 111: 34-46.
[14] 刘 静, 黄 东. 缝隙连接蛋白43在慢性疼痛中的研究进展[J]. 中南大学学报: 医学版, 2018, 43(1): 95-99.
[15] Li Q Y, Xu H Y, Yang H J. Effect of proinflammatory factors TNF-α, IL-1β, IL-6 on neuropathic pain[J].J Chin Mater Med, 2017, 42(19): 3709-3712.
[16] Lastwika K J, Dunn C A, Solan J L, et al. Phosphorylation of connexin43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repair[J].J Cell Sci, 2019,21(5): 234633.
[17] Morioka N, Zhang F F, Nakamura Y, et al. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice[J].Brain Behav Immun, 2015, 49: 293-310.
[18] Deng M, Chen S R, Chen H, et al. Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic tolerance[J].J Neurochem, 2019, 148(2): 275-290.
[19] 张 欣, 申 乐, 黄宇光. 丝裂原活化蛋白激酶在糖尿病神经病理性疼痛中枢敏化和外周敏化中作用的研究进展[J]. 中国医学科学院学报, 2019, 41(1): 118-123.
[20] Sanna M D, Ghelardini C, Galeotti N. Activation of JNK pathway in spinal astrocytes contributes to acute ultra-low-dose morphine thermal hyperalgesia[J]. Pain, 2015, 156(7): 1265-1275.
[21] 谢楚莉, 刘 欢, 孙宇翔,等. 脊髓星形胶质细胞通过调控Cx43-JNK通路介导吗啡耐受[J]. 解剖学研究,2018,40(2):127-131.
[22] 王 萌, 高小茹, 张冬梅, 等. JNK 对舒芬太尼预处理缺氧/复氧损伤心肌细胞 Cx43 表达的影响[J]. 宁夏医科大学学报, 2017, 39(2): 131-134.
[23] Qian Y, Wang Q, Jiao J, et al. Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3/ERK1/2 in a mouse model of chronic neuropathic pain[J].Neurol Res, 2019: 1-10.
[24] 赵青赞, 李治华, 任秀花, 等. 谷氨酸在星形胶质细胞培养中对 CX43 磷酸化的调节机制[J]. 神经解剖学杂志, 2015, 31(1): 19-24.
[25] Caraci F, Merlo S, Drago F, et al. Rescue of noradrenergic system as a novel pharmacological strategy in the treatment of chronic pain: focus on microglia activation[J].Front Pharmacol, 2019, 10.